Delcath Systems Inc - Company & Market Research Reports

Delcath is a pharmaceutical company with a focus on producing medication for oncology. Their drug Melphalan Hydrochloride with the Delcath Hepatic Delivery System (Melphalan/HDS) is used to deliver high doses of chemotherapy to the liver. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In April 2012, we obtained authorization to affix a CE Mark for the Generation Two CHEMOSAT system.